New hope for sarcopenic obesity: expanded access program opens
NCT ID NCT06784297
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This program offers expanded access to IMM01-STEM, an experimental treatment for sarcopenic obesity—a condition combining muscle loss and obesity. It is for patients who cannot join ongoing clinical trials due to location, eligibility, or other reasons. Participants receive weekly injections for four weeks. The goal is to provide potential benefit while more data is collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
IMM01-STEM (a stem cell-derived protein injection)
What this could lead to
If successful, this could provide a treatment option for people with sarcopenic obesity who cannot join standard clinical trials.
What could go wrong
This is an expanded access program, not a full clinical trial, so data on effectiveness and safety is limited. The treatment is still experimental.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.